Fast-track biopsy and surgery for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study combines targeted prostate biopsy with rapid on-the-spot testing and immediate surgery for men at high risk of aggressive prostate cancer. It aims to speed up diagnosis and treatment, potentially improving outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected prostate cancer based on a physical exam or PSA test.
- Your PSA blood test is between 4 and 100 ng/mL.
- You have had an MRI scan of your prostate.
- Your risk of having significant prostate cancer is 60% or higher (based on a clinical prediction model).
- You are healthy enough to undergo a prostate biopsy or surgery to remove the prostate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests removing the entire prostate gland (radical prostatectomy) without doing a biopsy first. It is for men with a very high PSA and strong imaging signs of cancer that has not spread, so they can start treatment sooner.
This study checks whether a faster prostate MRI and image-matching (image-fusion) can better find suspicious spots so doctors can target a biopsy. If you have concerning prostate exam results or PSA blood test results, you may get an MRI and, if something looks suspicious, a biopsy using MRI images.
This trial tests different drugs before prostate surgery based on a person's genetic profile. It aims to find better treatments for high-risk prostate cancer that hasn't spread yet.
This study aims to use precision medicine (tailored treatment based on your specific cancer) for men at high risk of prostate cancer. It may help doctors choose the best treatment for you.
This study tracks men with intermediate-risk prostate cancer who had a newer, targeted treatment that only treats the cancer area, not the whole prostate. It aims to see how well these treatments work in real life and may help guide future care.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.